cis-Active structural motifs involved in specific encapsidation of Moloney murine leukemia virus RNA

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 5043-5050

  Mougel, Marylene ^a,b   Zhang, Yaqiang ^a   Barklis, Eric ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 0030001105     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.5043-5050.1996     Document Type: Article

References (43)

1. Adam, M. A., and A. D. Miller. 1988. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J. Virol. 62:3802-3806.
2. Aldovini, A., and R. A. Young. 1990. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64:1920-1926.
3. Alford, R. L., C. Honda, C. B. Lawrence, and J. W. Belmont. 1991. RNA secondary structure analysis of the packaging signal for Moloney murine leukenia virus. Virology 183:611-619.
4. Barklis, E., R. C. Mulligan, and R. Jaenish. 1986. Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell 47:391-399.
5. Bender, M. A., T. D. Palmer, R. E. Gelinas, and A. D. Miller. 1987. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 61:1639-1646.
6. Berkowitz, R D., and S. P. Goff. 1994. Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein. Virology 202:233-246.
7. Berkowitz, R. D., A. Ohagen, S. Hoglund, and S. P. Goff. 1995. Retroviral nucleocapsid domains mediates the specificity recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. J. Virol. 69:6445-6456.
8. Berlioz, C., and J. L. Darlix. 1995. An internal ribosomal entry mechanism promotes translation of murine leukamia virus Gag polyprotein precursors. J. Virol. 69:2214-2222.
9. Bieth, E., C. Gabus, and J. L. Darlix. 1990. A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesis in vitro. Nucleic Acids Res. 18:119-127.
10. Cepko, C., B. Roberts, and R. Mulligan. 1984. Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell 37:1053-1062.
11. Cone, R. A. Weber-Benarous, X. Baorto, and R. Mulligan. 1987. Regulated expression of a complete human beta-globin gene encoded by a transmissible retrovirus vector. Mol. Cell. Biol. 7:887-897.
12. Dannull, J., A. Surovoy, G. Jung, and K. Moelling. 1994. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J. 13:1525-1533.
13. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
14. Gilboa, E., S. W. Mitra, S. Goff, and D. Baltimore. 1979. A detailed model of reverse transcription and tests of crucial aspects. Cell 18:93-100.
15. Gorelick, R. J., S. M. Nigida, J. R. W. Bess, L. O. Arthur, L. E. Henderson, and A. Rein. 1990. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 64:3207-3211.
16. Graham, R., and A. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus. Virology 52:456-467.
17. Hansen, M., L. Jelinek, R. Jones, J. Stegeman-Olsen, and E. Barklis. 1993. Assembly and composition of intracellular particles formed by Moloney murine leukemia virus. J. Virol. 67:5163-5174.
18. Jorgensen, R., S. Rothstein, and W. Reznikoff. 1979. A restriction enzyme cleavage map of Tn5 and location of a region encoding neomycin resistance. Mol. Gen. Genet. 177:65-72.
19. Konings, D. A., M. A. Nash, J. V. Maizel, and R. B. Arlinghaus. 1992. Novel GACG-hairpin motif in the 5′ untranslated region of type C retroviruses related to murine leukemia virus. J. Virol. 66:632-640.
20. Lee, P. P., and M. L. Linial. 1990. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal. J. Virol. 68:6644-6654.
21. Mace, M. C., M. Hansen, S. Whiting, C. T. Wang, and E. Barklis. 1992. Retroviral envelope protein fusions to secreted and membrane markers. Virology 188:869-874.
22. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory. Cold Spring Harbor, N.Y.
23. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
24. Mann, R., and D. Baltimore. 1985. Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs. J. Virol. 54:401-407.
25. Mann, R., R. Mulligan, and D. Baltimore. 1983. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33:153-159.
26. Mougel, M. Unpublished observations.
27. Mougel, M., N. Tounekti, J. L. Darlix, J. Paolelti, B. Ehresmann, and C. Ehresmann. 1993. Conformational analysis of the 5′ leader and the gag initiation site of Mo-MuLV RNA and allosteric transitions induced by dimerization. Nucleic Acids Res. 20:4677-4684.
28. Parker, B., and G. Stark. 1979. Regulation of simian virus 40 transcription: sensitive analysis of the RNA species present early in infection by virus or viral DNA. J. Virol. 31:360-369.
29. Peckham, I., S. Sobel, J. Comer, R. Jaenisch, and E. Barklis. 1989. Retrovirus activation in embryonal carcinoma cells by cellular promoters. Genes Dev. 3:2062-2071.
30. Prats, A. C., C. Roy, P. Wang, M. Erard, V. Housset, C. Gabus, C. Paoletti, and J. L. Darlix. 1990. cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA. J. Virol. 64:774-783.
31. Rattray, A. J., and J. J. Champoux. 1987. The role of Moloney murine leukemia virus RNase H activity in the formation of plus-strand primers. J. Virol. 61:2843-2851.
32. Reik, W., H. Weiher, and R. Jaenisch. 1985. Replication-competent M-MuLV carrying a bacterial suppressor tRNA gene: selective cloning of proviral and flanking host sequences. Proc. Natl. Acad. Sci. USA 82:1141-1145.
33. Roy, C., N. Tounekti, M. Mougel, J. L. Darlix, C. Paoletti, C. Ehresmann, B. Ehresmann, and J. Paoletti. 1990. An analytical study of the dimerization of in vitro generated RNA of Moloney murine leukemia virus MoMuLV. Nucleic Acids Res. 18:7287-7292.
34. Schwartzberg, P. J. Colicelli, and S. P. Goff. 1983. Deletion mutants of Moloney murine leukemia virus which lack glycosylated Gag protein are replication competent. J. Virol. 46:538-546.
35. Shinnick, T., R. Lerner, and J. Sutcliffe. 1981. Nucleotide sequence of Moloney murine leukemia virus. Nature (London) 293:543-548.
36. Stuhlmann, H., and P. Berg. 1992. Homologous recombination of copackaged retrovirus RNAs during reverse transcription. J. Virol. 66:2378-2388.
37. Stuhlmann, H., M. Dieckmann, and P. Berg. 1990. Transduction of cellular neo mRNA by retrovirus-mediated recombination. J. Virol. 64:5783-5796.
38. Tchenio, T., and T. Heidmann. 1995. The dimerization/packaging sequence is dispensable for both the formation of high-molecular-weight RNA complexes within retroviral particles and the synthesis of proviruses of normal structure. J. Virol. 69:1079-1084.
39. Tounekti, N., M. Mougel, C. Roy, M. Marquet, J. L. Darlix, J. Paoletti, B. Ehresmann, and C. Ehresmann. 1992. Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA. J. Mol. Biol. 223:205-220.
40. Wang, C. T., Y. Zhang, J. McDermott, and E. Barklis. 1993. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J. Virol. 67:7067-7076.
41. Weiher, H., E. Barklis, W. Ostertag, and R. Jaenisch. 1987. Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells. J. Virol. 61:2742-2746.
42. Yang, S., and H. M. Temin. 1994. A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J, 13:713-726.
43. Zhang, Y., and E. Barklis. 1995. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. J. Virol. 69:5716-5722.